PRUDENTIAL FINANCIAL INC

Position in CLDX — Celldex Therapeutics, Inc.

CIK 1137774 NEWARK, NJ

Position in CLDX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$621,332

+$291,349 QoQ

Shares Held

16,698

+60.5% QoQ

Ownership

0.021%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#140

of 252 holders

Holding Since

Sep 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PRUDENTIAL FINANCIAL INC holds $556,047,667 across 189 Biotechnology names. CLDX ranks #77 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	130,659	$81,471,112
2	VRTX	Vertex Pharmaceuticals Inc / Ma	133,294	$66,211,127
3	BMRN	Biomarin Pharmaceutical Inc	392,811	$22,476,644
4	INCY	Incyte Corp	191,312	$21,687,128
5	CYTK	Cytokinetics Inc	214,535	$18,276,236
6	LGND	Ligand Pharmaceuticals Inc	54,623	$17,265,784
7	PTCT	Ptc Therapeutics, Inc.	185,820	$15,157,337
8	MRVI	Maravai Lifesciences Holdings, Inc.	2,152,154	$13,429,440

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$621,332	16,698	+60.5%	Shares	Defined	2026-08-12
2026-03-31	$329,983	10,403	+18.1%	Shares	Defined	2026-05-13
2025-09-30	$227,888	8,809	-87.1%	Shares	Defined	2025-11-13
2024-09-30	$2,327,329	68,471	-6.1%	Shares	Defined	2024-11-14
2024-06-30	$2,698,066	72,901	+417.5%	Shares	Defined	2024-08-13
2024-03-31	$591,189	14,086	-75.5%	Shares	Defined	2024-05-14
2023-06-30	$1,954,401	57,601	-39.1%	Shares	Defined	2023-08-11
2023-03-31	$3,403,743	94,601	-17.5%	Shares	Defined	2023-05-12
2022-12-31	$5,108,435	114,616	+40.4%	Shares	Defined	2023-02-14
2022-09-30	$2,294,366	81,621	+2002.0%	Shares	Defined	2022-11-04
2021-09-30	$209,643	3,883	—	Shares	Defined	2021-11-15
No filing history on record for this holder in this stock.